glp 1 migraines Study finds GLP-1 drug cut migraine frequency by nearly half Could drugs like Ozempic, Saxenda,

Eli Lilly has sued pharmacies and telehealth companies trying to stop them from selling compounded versions of its products

Expanding healthcare systems in countries such as China and India, along with improved access to advanced therapies, are strengthening demand for effective glucose-lowering and weight-management treatments

Does not directly affect the cardiovascular system or the hormonal levels of GH and IGF-1

Synthesizing these findings, we outline emerging combination strategies that concurrently target ferroptosis and cuproptosis, and discuss current challenges and future directions for translating these concepts into precision therapies for OSCC